BCL6 and lymphoma: While TFAP4 was an essential gene in 48% of the cell lines and BCL6 was a lymphoma-specific essential gene, the other 6 in vivo hits showed little evidence of depletion across all cancer types, including 9 osteosarcoma cell lines (Supplementary Fig. 7).